News

9 November 2021

BAP Pharma Granted Clinical Secondary Packaging and Labelling Licence

BAP Pharma are pleased to announce that the Government of Upper Bavaria (Regierung von Oberbayern) have granted a Clinical Secondary Packaging and Labelling licence, to our German facility.

The new licence will enable BAP Pharma to offer bespoke Clinical Trial Secondary Packaging and Labelling services, to complement our award-winning Comparator Sourcing Division.

Clinical Secondary Packaging and Labelling Services:

  • Packaging & Label Design, Randomisation and Language Translations
  • Controlled Room Temperature and Cold Chain Packaging and Labelling
  • Global Storage, Distribution, Returns and Destruction
  • JIT (Just In Time) and On-Demand Labelling
  • QP Advice, Declaration and Certification

Our Clinical Secondary Packaging and Labelling service culminates in the creation of patient kits, which are distributed through our Global Storage and Distribution network. This ensures delivery to the right place, at the right time and in the right condition, to patients’ participating in clinical trials across the globe.

 

“This is a great achievement for our Bavarian facility and testament to our excellent team. Our new packaging and labelling capabilities will complement our additional services and further strengthen our clinical trial supply offering”.

Simon Magness, Managing Director BAP Pharma GmbH.

 

You Might Also Like

Exclusive Agreement For The Supply and Distribution Of Bicillin® LA

BAP Pharma Limited is pleased to announce the signing of an exclusive agreement for the supply and distribution of Bicillin® L-A (Penicillin G Benzathine) to expand access to the product in the UK and Europe (previously only available in the US)   Product Details Bicillin® L-A is a ready-to-use Benzathine

Exclusive Agreement For The Supply and Distribution Of Bicillin® LA

Minority Supplier Development UK Report 2021

We are excited and proud to announce that BAP Pharma have ranked 78th in the Minority Supplier Development UK Report 2021 – the first ever list of the country’s top 100 minority businesses. The Minority Supplier Development UK (MSDUK) is the UK’s premier not-for-profit membership organisation, championing diversity and inclusion

Minority Supplier Development UK Report 2021

BAP Pharma awarded Thames Valley 250 Special Recognition Award

BAP Pharma are the proud recipients of the Thames Valley 250 Special Recognition Award. The Thames Valley 250 Special Recognition Award is presented to a company that has shown outstanding achievement, innovation and commitment, while significantly contributing to the Thames Valley economy and the wider community. In 2020, BAP Pharma

BAP Pharma awarded Thames Valley 250 Special Recognition Award